P53 mediates estradiol induced activation of apoptosis and DNA repair in non-malignant colonocytes

Journal of Steroid Biochemistry and Molecular Biology

Volumn 128, Issue 3-5, 2012, Pages 113-120

  Weige, Charles C ^a   Allred, Kimberly F ^a   Armstrong, Cameron M ^a   Allred, Clinton D ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Apoptosis; Cancer; Colon; Estradiol; p53; Prevention

Indexed keywords

DOUBLE STRANDED DNA; ESTRADIOL; ESTROGEN RECEPTOR BETA; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER RISK; COLONOCYTE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; DRUG MECHANISM; GENE EXPRESSION; INTESTINE CELL; MOUSE; NONHUMAN; PROTEIN STABILITY; RADIATION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE; COLON; COLONIC NEOPLASMS; DNA; DNA REPAIR; ENTEROCYTES; ESTRADIOL; GENES, REPORTER; MICE; MUTANT PROTEINS; POINT MUTATION; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

ANIMALIA; MUS;

EID: 84855672088     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2011.10.010     Document Type: Article

References (54)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer Statistics, 2010 CA: Cancer J. Clin. 60 2010 277 300
2. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick, R.D. Jackson, S.A. Beresford, B.V. Howard, K.C. Johnson, J.M. Kotchen, and J. Ockene Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial Jama 288 2002 321 333 (Pubitemid 34761611)
3. E.E. Calle, H.L. Miracle-McMahill, M.J. Thun, and C.W. Heath Jr. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women J. Natl. Cancer Inst. 87 1995 517 523
4. S. Franceschi, S. Gallus, R. Talamini, A. Tavani, E. Negri, and C. La Vecchia Menopause and colorectal cancer Br. J. Cancer 82 2000 1860 1862 (Pubitemid 30307400)
5. M. Hoffmeister, E. Raum, A. Krtschil, J. Chang-Claude, and H. Brenner No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy Clin. Pharmacol. Ther. 2009
6. P.A. Newcomb, Y. Zheng, V.M. Chia, L.M. Morimoto, V.P. Doria-Rose, A. Templeton, S.N. Thibodeau, and J.D. Potter Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women Cancer Res. 67 2007 7534 7539 (Pubitemid 47206584)
7. P. Smirnoff, Y. Liel, J. Gnainsky, S. Shany, and B. Schwartz The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor Oncol. Res. 11 1999 255 264
8. J.Y. Guo, X. Li, J.D. Browning Jr., G.E. Rottinghaus, D.B. Lubahn, A. Constantinou, M. Bennink, and R.S. MacDonald Dietary soy isoflavones and estrone protect ovariectomized ERalphaKO and wild-type mice from carcinogen-induced colon cancer J. Nutr. 134 2004 179 182 (Pubitemid 38057444)
9. C.C. Weige, K.F. Allred, and C.D. Allred Estradiol alters cell growth in nonmalignant colonocytes and reduces the formation of preneoplastic lesions in the colon Cancer Res. 69 2009 9118 9124
10. N. Arai, A. Strom, J.J. Rafter, and J.A. Gustafsson Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein Biochem. Biophys. Res. Commun. 270 2000 425 431 (Pubitemid 30446852)
11. M. Di Domenico, G. Castoria, A. Bilancio, A. Migliaccio, and F. Auricchio Estradiol activation of human colon carcinoma-derived Caco-2 cell growth Cancer Res. 56 1996 4516 4521 (Pubitemid 26330464)
12. L.A. Gilad, T. Bresler, J. Gnainsky, P. Smirnoff, and B. Schwartz Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells J. Endocrinol. 185 2005 577 592 (Pubitemid 40883402)
13. Y. Nakayama, H. Sakamoto, K. Satoh, and T. Yamamoto Tamoxifen and gonadal steroids inhibit colon cancer growth in association with inhibition of thymidylate synthase, survivin and telomerase expression through estrogen receptor beta mediated system Cancer Lett. 161 2000 63 71
14. S. Singh, C. Paraskeva, P.H. Gallimore, M.C. Sheppard, and M.J. Langman Differential growth response to oestrogen of premalignant and malignant colonic cell lines Anticancer Res. 14 1994 1037 1041 (Pubitemid 24272564)
15. H.F. Turk, S.S. Kolar, Y.Y. Fan, C.A. Cozby, J.R. Lupton, and R.S. Chapkin Linoleic acid and butyrate synergize to increase Bcl-2 levels in colonocytes Int. J. Cancer 128 2011 63 71
16. K. Uchiyama, Y. Naito, T. Takagi, K. Mizushima, N. Hayashi, A. Harusato, I. Hirata, T. Omatsu, O. Handa, T. Ishikawa, N. Yagi, S. Kokura, and T. Yoshikawa Carbon monoxide enhance colonic epithelial restitution via FGF15 derived from colonic myofibroblasts Biochem. Biophys. Res. Commun. 391 2010 1122 1126
17. M.S. Greenblatt, W.P. Bennett, M. Hollstein, and C.C. Harris Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis Cancer Res. 54 1994 4855 4878 (Pubitemid 24289415)
18. H.S. Goh, C.S. Chan, K. Khine, and D.R. Smith p53 and behaviour of colorectal cancer Lancet 344 1994 233 234 (Pubitemid 24229012)
19. H.S. Goh, J. Yao, and D.R. Smith p53 point mutation and survival in colorectal cancer patients Cancer Res. 55 1995 5217 5221
20. M.C. Hollstein, L. Peri, A.M. Mandard, J.A. Welsh, R. Montesano, R.A. Metcalf, M. Bak, and C.C. Harris Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations Cancer Res. 51 1991 4102 4106
21. A.J. Levine, A. Chang, D. Dittmer, D.A. Notterman, A. Silver, K. Thorn, D. Welsh, and M. Wu The p53 tumor suppressor gene J. Lab. Clin. Med. 123 1994 817 823 (Pubitemid 2103596)
22. B. Vogelstein, D. Lane, and A.J. Levine Surfing the p53 network Nature 408 2000 307 310
23. K.H. Vousden, and C. Prives Blinded by the light: the growing complexity of p53 Cell 137 2009 413 431
24. S.A. Lewandowski, J. Thiery, A. Jalil, G. Leclercq, C. Szczylik, and S. Chouaib Opposite effects of estrogen receptors alpha and beta on MCF-7 sensitivity to the cytotoxic action of TNF and p53 activity Oncogene 24 2005 4789 4798 (Pubitemid 41076296)
25. L.A. Helguero, M.H. Faulds, J.A. Gustafsson, and L.A. Haldosen Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11 Oncogene 24 2005 6605 6616 (Pubitemid 41486791)
26. S. Bovenkerk, N. Lanciloti, and N. Chandar Induction of p53 expression and function by estrogen in osteoblasts Calcif. Tissue Int. 73 2003 274 280 (Pubitemid 37152889)
27. X. Zhi, K. Honda, T. Sumi, T. Yasui, H. Nobeyama, H. Yoshida, and O. Ishiko Estradiol-17beta regulates vascular endothelial growth factor and Bcl-2 expression in HHUA cells Int. J. Oncol. 31 2007 1333 1338
28. W.S. el-Deiry, T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein WAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817 825 (Pubitemid 23346378)
29. A.R. Villalobos, and J.L. Renfro Trimethylamine oxide suppresses stress-induced alteration of organic anion transport in choroid plexus J. Exp. Biol. 210 2007 541 552 (Pubitemid 46347927)
30. R.H. Whitehead, P.E. VanEeden, M.D. Noble, P. Ataliotis, and P.S. Jat Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice Proc. Natl. Acad. Sci. U.S.A. 90 1993 587 591 (erratum appears in Proc. Natl. Acad. Sci. U.S.A. 1993 Jul 15;90(14):6894) (Pubitemid 23028908)
31. M. Xia, and H. Land Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility Nat. Struct. Mol. Biol. 14 2007 215 223 (Pubitemid 46355577)
32. J.F. Kerr, C.M. Winterford, and B.V. Harmon Apoptosis. Its significance in cancer and cancer therapy Cancer 73 1994 2013 2026 (Pubitemid 24107952)
33. S.W. Lowe, H.E. Ruley, T. Jacks, and D.E. Housman p53-dependent apoptosis modulates the cytotoxicity of anticancer agents Cell 74 1993 957 967 (Pubitemid 23289454)
34. S.W. Lowe, S. Bodis, A. McClatchey, L. Remington, H.E. Ruley, D.E. Fisher, D.E. Housman, and T. Jacks p53 status and the efficacy of cancer therapy in vivo Science 266 1994 807 810 (Pubitemid 24359290)
35. P. Shaw, R. Bovey, S. Tardy, R. Sahli, B. Sordat, and J. Costa Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line Proc. Natl. Acad. Sci. U.S.A. 89 1992 4495 4499
36. D. Dittmer, S. Pati, G. Zambetti, S. Chu, A.K. Teresky, M. Moore, C. Finlay, and A.J. Levine Gain of function mutations in p53 Nat. Genet. 4 1993 42 46 (Pubitemid 23165910)
37. Y.H. Peng, L.H. Chen, C.G. Li, W.G. Lu, S. Agrawal, and J.D. Chen Stabilization of the MDM2 oncoprotein by mutant p53 J. Biol. Chem. 276 2001 6874 6878
38. T. Schilling, A. Kairat, G. Melino, P.H. Krammer, W. Stremmel, M. Oren, and M. Muller Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma Biochem. Biophys. Res. Commun. 394 2010 817 823
39. A. Bielecki, J. Roberts, R. Mehta, and J. Raju Estrogen receptor-beta mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones Nutr. Cancer Int. J. 63 2011 139 150
40. J. Hartman, K. Edvardsson, K. Lindberg, C.Y. Zhao, C. Williams, A. Strom, and J.A. Gustafsson Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells Cancer Res. 69 2009 6100 6106
41. D.B. Woods, and K.H. Vousden Regulation of p53 function Exp. Cell Res. 264 2001 56 66 (Pubitemid 32989081)
42. Y. Ogawara, S. Kishishita, T. Obata, Y. Isazawa, T. Suzuki, K. Tanaka, N. Masuyama, and Y. Gotoh Akt enhances Mdm2-mediated ubiquitination and degradation of p53 J. Biol. Chem. 277 2002 21843 21850 (Pubitemid 34952337)
43. R. Honda, and H. Yasuda Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53 EMBO J. 18 1999 22 27 (Pubitemid 29005019)
44. M. Li, C.L. Brooks, F. Wu-Baer, D. Chen, R. Baer, and W. Gu Mono- versus polyubiquitination: differential control of p53 fate by Mdm2 Science 302 2003 1972 1975 (Pubitemid 37523506)
45. S.L. Harris, and A.J. Levine The p53 pathway: positive and negative feedback loops Oncogene 24 2005 2899 2908 (Pubitemid 40638098)
46. N.N. Danial, and S.J. Korsmeyer Cell death: critical control points Cell 116 2004 205 219 (Pubitemid 38167313)
47. K.G. Wolter, Y.T. Hsu, C.L. Smith, A. Nechushtan, X.G. Xi, and R.J. Youle Movement of Bax from the cytosol to mitochondria during apoptosis J. Cell Biol. 139 1997 1281 1292 (Pubitemid 27523214)
48. T. Rosse, R. Olivier, L. Monney, M. Rager, S. Conus, I. Fellay, B. Jansen, and C. Borner Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c Nature 391 1998 496 499 (Pubitemid 28086551)
49. I. Sturm, C.H. Kohne, G. Wolff, H. Petrowsky, T. Hillebrand, S. Hauptmann, M. Lorenz, B. Dorken, and P.T. Daniel Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases J. Clin. Oncol. 17 1999 1364 1374 (Pubitemid 29220841)
50. X. Wang, and T. Ohnishi p53-dependent signal transduction induced by stress J. Radiat. Res. (Tokyo) 38 1997 179 194 (Pubitemid 127461818)
51. K. Edvardsson, A. Strom, P. Jonsson, J.A. Gustafsson, and C. Williams Estrogen receptor beta induces antiinflammatory and antitumorigenic networks in colon cancer cells Mol. Endocrinol. 25 2011 969 979
52. A. Pedram, M. Razandi, A.J. Evinger, E. Lee, and E.R. Levin Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair Mol. Biol. Cell 20 2009 3374 3389
53. A. Kurose, T. Tanaka, X. Huang, F. Traganos, and Z. Darzynkiewicz Synchronization in the cell cycle by inhibitors of DNA replication induces histone H2AX phosphorylation: an indication of DNA damage Cell. Prolif. 39 2006 231 240
54. J.H. Lee, Y. Kang, V. Khare, Z.Y. Jin, M.Y. Kang, Y. Yoon, J.W. Hyun, M.H. Chung, S.I. Cho, J.Y. Jun, I.Y. Chang, and H.J. You The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage Oncogene 29 2010 1431 1450